CSPC Pharmaceutical Group has announced that its new product, SYS6041, an antibody-drug conjugate, has received clinical trial approval from China’s National Medical Products Administration.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Jefferies analyst David Shang maintained a Hold rating on CSPC Pharmaceutical Group (CHJTF – Research Report) today and set a price target of HK$4.60. The company’s shares closed last Monday ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and internationally, ...

Shell Nanhai BV and CNOOC have taken final investment decision to proceed with the proposed third major expansion of ethylene production capacity at the CSPC petrochemical complex in Guangdong ...

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.

China National Offshore Oil Corporation (CNOOC) and Shell plc's joint venture, CNOOC and Shell Petrochemicals Company Limited (CSPC), announced Wednesday they would invest in the Huizhou Phase III ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...